Jorge Santos da Silva
2022
In 2022, Jorge Santos da Silva earned a total compensation of $4.5M as Chief Executive Officer at MoonLake Immunotherapeutics, a 11% decrease compared to previous year.
Compensation breakdown
| Bonus | $632,878 |
|---|---|
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $30,404 |
| Salary | $460,275 |
| Stock Awards | $3,362,817 |
| Other | $21,411 |
| Total | $4,507,785 |
Silva received $3.4M in stock awards, accounting for 75% of the total pay in 2022.
Silva also received $632.9K in bonus, $30.4K of change in pension value and nonqualified deferred compensation earnings, $460.3K in salary and $21.4K in other compensation.
Rankings
In 2022, Jorge Santos da Silva's compensation ranked 724th out of 5,625 executives tracked by ExecPay. In other words, Silva earned more than 87.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 724 out of 5,625 | 87th |
Division Manufacturing | 321 out of 3,053 | 90th |
Major group Chemicals And Allied Products | 101 out of 1,380 | 93rd |
Industry group Drugs | 88 out of 1,281 | 93rd |
Industry Pharmaceutical Preparations | 66 out of 927 | 93rd |
Source: SEC filing on April 26, 2023.
Silva's colleagues
We found two more compensation records of executives who worked with Jorge Santos da Silva at MoonLake Immunotherapeutics in 2022.